Racial differences in clinical outcome using tacrolimus and mycophenolate mofetil immunosuppression in heart transplantation.
The Ochsner Cardiomyopathy and Heart Transplantation Center, Ochsner Medical Institutions, New Orleans, Louisiana, USA. mmehra@ochsner.org
M R
MR
Mehra
P A
PA
Uber
R L
RL
Scott
A K
AK
Prasad
M H
MH
Park
D044383:Black People; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000235:genetics / Q000517:prevention & control*; D016027:Heart Transplantation / Q000276:immunology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D009173:Mycophenolic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use*; D011446:Prospective Studies; D016019:Survival Analysis; D016559:Tacrolimus / Q000627:therapeutic use*; D016896:Treatment Outcome; D044465:White People
D007166:Immunosuppressive Agents; D009173:Mycophenolic Acid; D016559:Tacrolimus